News

Animalcare Group plc is an LSE AIM listed international veterinary sales and marketing organisation. The Company operates in seven European countries as well as Australia and New Zealand and exports to approximately 40 countries in Europe and worldwide.

The Group is focused on bringing new and innovative products to market through its own development pipeline, partnerships and via acquisition.

Charterhouse Capital Partners is one of the longest established private equity firms operating in Europe. They follow a selective, conviction-led approach to investing in high-quality mid-market European companies.

The Company invests with a growth-focused approach to mid-market European companies across the services and healthcare sectors. They follow a selective, conviction-led style, sourcing attractive investment opportunities often ahead of any process with the long-term ambition of driving transformational change.

On 16 April 2026, the boards of directors of CCP Paw 2 Limited – a wholly-owned indirect subsidiary of funds managed or advised by Charterhouse (Bidco) and Animalcare announced that they had reached agreement on the terms and conditions of a recommended acquisition by Bidco of the entire issued, and to be issued, share capital of Animalcare, with a valuation of approximately £235.2 million on a fully diluted basis.

Publication of Scheme Document

The Perivan shareholder communications team was delighted to work with Squire Patton Boggs who acted as legal adviser to Animalcare on the Scheme and associated documents, which were successfully published and posted to qualifying shareholders on 12 May 2026.

For more information, click here.

Perivan specialise in producing and publishing financial documents relating to shareholder and investor communications for quoted companies and are a market leader for the production of documentation relating to Mergers & Acquisitions.